Clinical Trial: A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia)

U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07391241) titled 'A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia)' on Jan. 21.

Brief Summary: The study (IP2015CS05) is a randomised, double-blind, placebo-controlled, 4-way cross-over trial studying the efficacy and safety of single dose administration of pudafensine in vulvodynia (provoked vestibulodynia) patients.

Study Start Date: Dec. 17, 2025

Study Type: INTERVENTIONAL

Condition: Vulvodynia

Intervention: DRUG: Pudafensine

Pudafensine

Recruitment Status: RECRUITING

Sponsor: Initiator Pharma

Published by HT Digital Content Services with permission from Health Daily Digest....